AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: The activated phosphatidyl inositol (PI3K)/AKT pathways have been implicated in the excessive oxidative state from mitochondrial dysfunction in CML progenitor cells and have been shown to play a role in the development of TKI resistance [52,53].